Back to Industry News
Medtech
Bloomberg: Goldman Sachs Leads $3.75B Debt Deal for DuPont Unit
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Bloomberg.com
Photo by Bergstrand Consultancy on Unsplash
Stay updated on stories like this
Key takeaways
- Goldman Sachs Group Inc
- 75 billion debt financing package to support Arclin Inc
- 's acquisition of DuPont de Nemours Inc
Goldman Sachs Group Inc. is spearheading a $3.75 billion debt financing package to support Arclin Inc.'s acquisition of DuPont de Nemours Inc.'s Aramids business, according to a Bloomberg report.
The financing, comprised of a $3 billion term loan, a $250 million delayed-draw term loan, and a $500 million revolving credit facility, is currently being marketed to investors by Goldman Sachs. Sources familiar with the private transaction provided the details.
Related Topics
Goldman SachsDuPontArclindebt financingacquisition
Never miss stories like this